Press "Enter" to skip to content

Dr Reddy’s launches Trientine Hydrochloride capsules in US

In a regulatory filing, Dr Reddy’s Laboratories announced the launch of Trientine Hydrochloride capsules USP, 250 mg, a therapeutically equivalent generic version of Syprine (trientine hydrochloride) capsules approved by the US Food and Drug Administration (USFDA).

Original source: https://health.economictimes.indiatimes.com/news/pharma/dr-reddys-launches-trientine-hydrochloride-capsules-in-us/74021162?utm_source=RSS&utm_medium=ETRSS